Bioinformatic analysis and in vitro tests demonstrated the effect of RGS19 on the cell cycle and the inhibitory effect of GSK1070916 on BLCA with abnormally high expression of RGS19. Here, RGS19 is linked to bladder transitional cell carcinoma.